Bio-Rad Laboratories Pre-Paid Expenses 2010-2025 | BIO
Bio-Rad Laboratories pre-paid expenses from 2010 to 2025. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
- Bio-Rad Laboratories pre-paid expenses for the quarter ending March 31, 2025 were $0.125B, a 12.15% decline year-over-year.
- Bio-Rad Laboratories pre-paid expenses for 2024 were $0.123B, a 12.43% decline from 2023.
- Bio-Rad Laboratories pre-paid expenses for 2023 were $0.14B, a 12.74% increase from 2022.
- Bio-Rad Laboratories pre-paid expenses for 2022 were $0.124B, a 13.78% increase from 2021.
| Bio-Rad Laboratories Annual Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2024 | $123 |
| 2023 | $140 |
| 2022 | $124 |
| 2021 | $109 |
| 2020 | $91 |
| 2019 | $102 |
| 2018 | $187 |
| 2017 | $146 |
| 2016 | $91 |
| 2015 | $94 |
| 2014 | $108 |
| 2013 | $131 |
| 2012 | $92 |
| 2011 | $99 |
| 2010 | $110 |
| 2009 | $78 |
| Bio-Rad Laboratories Quarterly Pre-Paid Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $125 |
| 2024-12-31 | $123 |
| 2024-09-30 | $133 |
| 2024-06-30 | $153 |
| 2024-03-31 | $143 |
| 2023-12-31 | $140 |
| 2023-09-30 | $124 |
| 2023-06-30 | $123 |
| 2023-03-31 | $121 |
| 2022-12-31 | $124 |
| 2022-09-30 | $147 |
| 2022-06-30 | $131 |
| 2022-03-31 | $127 |
| 2021-12-31 | $109 |
| 2021-09-30 | $105 |
| 2021-06-30 | $111 |
| 2021-03-31 | $110 |
| 2020-12-31 | $91 |
| 2020-09-30 | $111 |
| 2020-06-30 | $92 |
| 2020-03-31 | $95 |
| 2019-12-31 | $102 |
| 2019-09-30 | $110 |
| 2019-06-30 | $122 |
| 2019-03-31 | $164 |
| 2018-12-31 | $187 |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | $146 |
| 2017-09-30 | $141 |
| 2017-06-30 | $126 |
| 2017-03-31 | |
| 2016-12-31 | $91 |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | $94 |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | $108 |
| 2014-09-30 | $191 |
| 2014-06-30 | $220 |
| 2014-03-31 | $228 |
| 2013-12-31 | $131 |
| 2013-09-30 | $131 |
| 2013-06-30 | $188 |
| 2013-03-31 | $183 |
| 2012-12-31 | $92 |
| 2012-09-30 | $158 |
| 2012-06-30 | $153 |
| 2012-03-31 | $159 |
| 2011-12-31 | $99 |
| 2011-09-30 | $147 |
| 2011-06-30 | $159 |
| 2011-03-31 | $181 |
| 2010-12-31 | $110 |
| 2010-09-30 | $142 |
| 2010-06-30 | $132 |
| 2010-03-31 | $126 |
| 2009-12-31 | $78 |
| 2009-09-30 | $127 |
| 2009-06-30 | $121 |
| 2009-03-31 | $132 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.474B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $240.237B | 28.89 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $147.507B | 30.84 |
| EssilorLuxottica (ESLOY) | France | $130.320B | 0.00 |
| Medtronic (MDT) | Ireland | $110.401B | 15.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.194B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.523B | 28.18 |
| Agilent Technologies (A) | United States | $33.417B | 21.78 |
| GE HealthCare Technologies (GEHC) | United States | $32.959B | 15.65 |
| Terumo (TRUMY) | Japan | $27.294B | 35.45 |
| Koninklijke Philips (PHG) | Netherlands | $23.014B | 16.15 |
| Insulet (PODD) | United States | $21.880B | 85.88 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.269B | 11.73 |
| Baxter (BAX) | United States | $15.698B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.073B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.601B | 14.13 |
| Prestige Consumer Healthcare (PBH) | United States | $4.184B | 18.69 |
| Perrigo (PRGO) | Ireland | $3.678B | 9.32 |
| Haemonetics (HAE) | United States | $3.510B | 15.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.221B | 23.75 |
| Envista Holdings (NVST) | United States | $3.210B | 26.68 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| QuidelOrtho (QDEL) | United States | $1.939B | 13.34 |
| LeMaitre Vascular (LMAT) | United States | $1.916B | 42.83 |
| AtriCure (ATRC) | United States | $1.621B | 0.00 |
| Acuren (TIC) | United States | $1.311B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.182B | 12.00 |
| Neogen (NEOG) | United States | $1.070B | 13.69 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.004B | 12.83 |
| Kestra Medical Technologies (KMTS) | United States | $0.906B | 0.00 |
| InMode (INMD) | Israel | $0.870B | 8.76 |
| CeriBell (CBLL) | United States | $0.710B | 0.00 |
| Evolus (EOLS) | United States | $0.620B | 0.00 |
| Owens & Minor (OMI) | United States | $0.578B | 4.79 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.519B | 0.00 |
| Valneva SE (VALN) | France | $0.477B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.423B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.328B | 12.05 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.10 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.22 |
| Brainsway (BWAY) | Israel | $0.232B | 61.30 |
| Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.229B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.224B | 66.33 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.74 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.121B | 14.84 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| MacroGenics (MGNX) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 59.43 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.89 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |